2-picoline has been researched along with Acute Confusional Senile Dementia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allen, JR; Amegadzie, A; Babu-Khan, S; Bartberger, MD; Biswas, K; Bradley, J; Chavez, F; Chen, JJ; Chen, N; Correll, TL; Dean, C; DeMorin, F; Hickman, D; Hitchcock, S; Hungate, R; Koegler, F; Liu, Q; Liu, Y; Luo, Y; McCarter, JD; Ncube, M; Nixey, T; Qian, W; Reid, DL; Rumfelt, S; Rzasa, RM; Tegley, CM; Wen, PH; Williamson, T; Wood, S; Yuan, C; Zalameda, L; Zhang, J; Zhu, J; Zhu, L | 1 |
1 other study(ies) available for 2-picoline and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Discovery of 2-methylpyridine-based biaryl amides as γ-secretase modulators for the treatment of Alzheimer's disease.
Topics: Alzheimer Disease; Amides; Amyloid Precursor Protein Secretases; Animals; HEK293 Cells; Humans; Picolines; Rats; Rats, Sprague-Dawley | 2013 |